ArticleFrontiers in psychology2023
Transformative experience and informed consent to psychedelic-assisted psychotherapy.
Article in Frontiers in psychology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Aspirational autonomy and psychedelic-assisted therapy in advanced cancer: ethical lessons from clinical cases.The oncologist · 2026Article
- Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically.Scientific reports · 2026Article
- Ethical Aspects of Psychedelic-Assisted Treatments: An Overview.Current topics in behavioral neurosciences · 2026Review
- Informed Consent in Psychedelic-Assisted Therapy.Current topics in behavioral neurosciences · 2026Review
- Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users.Psychopharmacology · 2025Article
- Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.Psychological medicine · 2025Article
- The Ethics of Set and Setting in Psychedelic Psychotherapy.Neuroethics · 2025Article
- Article
- Practical considerations in the establishment of psychedelic research programs.Psychopharmacology · 2025Review
- Excusing Psychedelics and Accommodating Psychedelics.The American journal of bioethics : AJOB · 2025Article
- Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.Therapeutic advances in psychopharmacology · 2025Review
- The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences.Therapeutic advances in psychopharmacology · 2025Article
- Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study.Scientific reports · 2024Article
- Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.Psychedelic medicine (New Rochelle, N.Y.) · 2024Article
- Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2024Article
- Giving Consent to the Ineffable.Neuroethics · 2024Article
- Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics.Public health ethicsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Just as psychedelic-assisted psychotherapy (PAP) represents a clinical innovation that may need to be accommodated with corresponding theoretical and methodological innovations, there is growing awareness that the tools, normative frameworks, and standard practices of our clinical ethics may also need to be adapted, renewed, or replaced to accommodate its unusual features. Drawing on L. A. Paul's work on "Transformative Experience," I argue that the acute and long-term effects that are repeatedly reported following the administration of psychedelic drugs, including in clinical contexts, are epistemically inaccessible at the point of deciding to take them. By virtue of both the so-called "mystical" experiences that frequently arise during PAP, and the long-term shifts to outlooks, values, and priorities that can follow treatment, the processes of decision-making that are normatively expected of patients run aground. If this framing is correct, then prospective patients cannot meet the requirement of understanding that is one of the principal analytic components of informed consent. The role of understanding in supporting two functions of informed consent-avoiding unauthorized trespass against patients and supporting values-aligned decision-making-is explored, and I argue that, while the normative standard for the first function may be met by extant suggestions for enhancing the consenting process for PAP, the latter function remains unattainable. In light of this, the consequences for the ethical preparation of prospective patients are considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.